Cellect Biotechnology Receives Approval for U.S. Clinical Trial
TEL AVIV, Israel, Dec. 23, 2019 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology to enable the functional selection of stem cells, ha…
More from St. Louis Metro
KTTN Radio | Trenton
Farmington man killed in crash with Freightliner truck
St. Louis Metro
•
3h ago
Webster Gorloks
Martins Ferreira's Late Goal Lifts Gorloks Past Principia, 1-0
St. Louis Metro
•
5h ago
Webster Gorloks
Volleyball Sweeps Senior Day Tri-Match with Wins Over Lyon and Spalding
St. Louis Metro
•
5h ago
KTVI FOX 2 NOW St. Louis
St. Louis City SC falls 3-2 to Minnesota, unbeaten streak comes to an end
St. Louis Metro
•
5h ago
KTVI FOX 2 NOW St. Louis
'No Kings' protests held in St. Louis region ahead of November midterms
St. Louis Metro
•
5h ago
